New active substances authorized in the United Kingdom between 1972 and 1994

British Journal of Clinical Pharmacology

Volumn 45, Issue 2, 1998, Pages 151-156

  Jefferys, David B ^a,c   Leakey, Diane ^a   Lewis, John A ^a   Payne, Sandra ^c   Rawlins, Michael D ^b,c  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^b University of Newcastle upon Tyne ^*  (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

New active substances; New biological substances; New biotechnology agents; New chemical entities; Product licences; Safety withdrawals

Indexed keywords

ALFADOLONE; AMIDEFRINE; ANESTHETIC AGENT; BENOXAPROFEN; BENTIROMIDE; BROTIZOLAM; CARDIOVASCULAR AGENT; CHEMICAL COMPOUND; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FAZADINIUM; FEPRAZONE; GLIBORNURIDE; IOCARMIC ACID; LATAMOXEF; LIDOFLAZINE; METILDIGOXIN; METRIZAMIDE; NEW DRUG; NOMIFENSINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXOLINIC ACID; RADIOPHARMACEUTICAL AGENT; SARALASIN; SISOMICIN; SUPROFEN; TIMOLOL; UNINDEXED DRUG; VIDARABINE; ZIMELDINE;

ARTICLE; BIOTECHNOLOGY; DRUG APPROVAL; DRUG MARKETING; DRUG SAFETY; DRUG WITHDRAWAL; LICENCE; MARKET; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; UNITED KINGDOM;

DATABASES, FACTUAL; DRUG APPROVAL; DRUG INFORMATION SERVICES; GREAT BRITAIN; LEGISLATION, DRUG; LICENSURE; PHARMACEUTICAL PREPARATIONS;

EID: 0031974544     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00651.x     Document Type: Article

References (9)

1. Hass AE, Coppinger PL. Introductions and discontinuations of new drugs in the United States and the United Kingdom 1970-88. Food & Drug Administration: Rockville, 1989.
2. Tansey IP, Armstrong NA, Walker SR. Trends in pharmaceutical innovation. The introduction of products on to the UK market 1960-89. J Pharm Med 1994; 4: 85-100.
3. Bakke OM, Wardell WM, Lasagna L. Drug discontinuations in the United Kingdom & the United States; 1964-83: Issues of safety. Clin Pharmacol Ther 1994; 35: 559-567.
4. Bakke OM, Manocchia M, de Abajo F, Kaitin KI, Lasagna L. Drug discontinuations for safety reasons: an update with comparison of UK, US & Spain 1974-93. Clin Pharmacol Ther 1995; 58: 108-117.
5. Commission of the European Communities. The Rules Governing Medicinal Products in the European Community. Volume II Notice to Applicants, 1994.
6. Martindale. The Extra Pharmacopoeia. Twenty-sixth Edition. Pharmaceutical Press: London, 1992.
7. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, 1995.
8. Public Citizen Health Research Group. Differences in the number of drug safety withdrawals United States, United Kingdom, Germany and France. Public Citizen Health Research Group: Washington, 1995.
9. Rawlins MD. Pharmacovigilance: Paradise Lost, Regained or Postponed? J Roy Coll Phys 1995; 29: 41-49.